Opportunity Information: Apply for CDC RFA PS13 131502CONT14
Apply for CDC RFA PS13 131502CONT14
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.941 HIV Demonstration, Research, Public and Professional Education Projects.
- This funding opportunity was created on Mar 26, 2014 and posted on Mar 26, 2014.
- Applicants must submit their applications by May 6, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under PS13 1315 Improving HIV Prevention and Treatment Outcomes Among HIV Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient Centered HIV Care.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP)," is a Centers for Disease Control and Prevention (CDC) continuation cooperative agreement tied to CDC Funding Opportunity Number CDC RFA PS13-131502CONT14. It was posted and created on March 26, 2014, with an application closing date of May 6, 2014, and an archive date of June 5, 2014. The opportunity sits within the health funding activity category and is associated with CFDA 93.941, which covers HIV demonstration, research, and public and professional education projects.
The key point about this announcement is that it is not an open competition. Eligibility is limited to a specific group: only organizations that were previously awarded under the earlier announcement PS13-1315, titled "Improving HIV Prevention and Treatment Outcomes Among HIV Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient Centered HIV Care," are intended to receive continuation funding. In other words, the purpose is to maintain or extend work already funded under PS13-1315 rather than to solicit new applicants or launch a brand-new program. The "Eligible Applicants" field is broadly labeled as "Others," but the eligibility clarification makes it clear that the continuation is intended only for existing PS13-1315 grantees.
The funding instrument is a cooperative agreement, which generally indicates a more hands-on partnership between the CDC and the recipient than a standard grant. Under cooperative agreements, the recipient carries out program activities, but the CDC typically has substantial involvement, such as providing technical assistance, guidance on implementation, performance monitoring, and collaboration on program improvements. While the announcement itself does not list specific deliverables in the excerpt provided, its linkage to PS13-1315 signals that the continued work centers on improving HIV prevention and treatment outcomes by integrating community pharmacists with clinical care sites in a patient-centered HIV care model. That kind of model usually focuses on strengthening continuity of care, supporting medication adherence, improving coordination among providers, and reducing barriers for people living with HIV to remain engaged in effective treatment.
Several standard funding fields in the record show zeros (estimated total funding, award ceiling, award floor), which typically means the public synopsis did not publish specific dollar amounts for this continuation notice, rather than implying that no funds would be awarded. The expected number of awards is listed as 50, suggesting the continuation could potentially cover a sizable cohort of existing recipients, consistent with a multi-site demonstration or implementation effort.
There is no cost-sharing or matching requirement stated for this opportunity, meaning recipients are not required to contribute non-federal funds as a condition of the award. This can be important for implementation-focused public health projects, where requiring match funding can limit participation or force recipients to divert resources from direct service and systems improvement work.
For applicants (again, limited to existing awardees) who have trouble accessing the full announcement electronically, the contact is the CDC Procurement and Grants Office (PGO). The listing provides a phone number, 770-488-2700, and an email contact, pgortim@cdc.gov, which would be the appropriate channel for technical access issues or administrative questions about the announcement.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP)."
Which agency is offering this funding opportunity?
This is a Centers for Disease Control and Prevention (CDC) funding opportunity.
Is this an open, competitive funding opportunity?
No. This announcement is not an open competition. It is a continuation cooperative agreement intended only for a specific set of previously funded organizations.
Who is eligible to apply?
Eligibility is limited to organizations that were previously awarded under the earlier announcement PS13-1315, titled "Improving HIV Prevention and Treatment Outcomes Among HIV Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient Centered HIV Care." Even though the "Eligible Applicants" field is labeled broadly as "Others," the eligibility clarification indicates only existing PS13-1315 awardees are intended to receive continuation funding.
What is the CDC Funding Opportunity Number associated with this continuation?
The continuation is tied to CDC Funding Opportunity Number CDC RFA PS13-131502CONT14.
What is the CFDA number and what does it cover?
The opportunity is associated with CFDA 93.941, which covers HIV demonstration, research, and public and professional education projects.
What type of funding instrument is being used?
The funding instrument is a cooperative agreement.
What does a cooperative agreement mean in practice?
A cooperative agreement generally indicates substantial CDC involvement in the funded work compared with a standard grant. The recipient carries out program activities, while CDC typically provides technical assistance, guidance on implementation, performance monitoring, and collaboration on program improvements.
What is the purpose of this continuation funding?
The purpose is to maintain or extend work already funded under PS13-1315 rather than to solicit new applicants or launch a new program. The continued work is linked to improving HIV prevention and treatment outcomes by integrating community pharmacists with clinical care sites into a patient-centered HIV care model.
What kinds of activities are implied by the referenced PS13-1315 model?
Based on the linkage to PS13-1315, the work centers on integrating community pharmacists and clinical sites in patient-centered HIV care. This type of model commonly emphasizes continuity of care, medication adherence support, stronger coordination among providers, and reducing barriers that keep people living with HIV engaged in effective treatment.
When was the opportunity posted and created?
The opportunity was posted and created on March 26, 2014.
What is the application closing date?
The application closing date is May 6, 2014.
When was the opportunity archived?
The archive date is June 5, 2014.
What is the funding activity category?
The opportunity sits within the health funding activity category.
How many awards are expected?
The expected number of awards is listed as 50.
Is cost sharing or matching required?
No cost-sharing or matching requirement is stated for this opportunity, meaning recipients are not required to contribute non-federal funds as a condition of the award.
Why do some funding fields show $0 (estimated total funding, award ceiling, award floor)?
The record shows zeros for several standard funding fields, which typically indicates the public synopsis did not publish specific dollar amounts for this continuation notice, rather than indicating that no funds would be awarded.
Who should be contacted if an eligible applicant cannot access the full announcement electronically?
For electronic access issues, the contact listed is the CDC Procurement and Grants Office (PGO).
What are the CDC PGO contact details provided in the listing?
Phone: 770-488-2700
Email: pgortim@cdc.gov
Is this opportunity meant to fund new applicants who were not part of PS13-1315?
No. The notice indicates continuation funding is intended only for existing PS13-1315 awardees, not new applicants.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Conservation Innovative Grants
Previous opportunity: Technical Assistance for Substance Abuse Treatment Providers in Peru for At Risk Women and Adolescents
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 131502CONT14
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 131502CONT14) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIAID Division of Allergy, Immunology and Transplantation Statistical and Clinical Coordinating Center (UM2) Apply for RFA AI 14 016 Funding Number: RFA AI 14 016 Agency: National Institutes of Health Category: Health Funding Amount: $16,500,000 |
| National Environmental Medicine Education and Consultation Project (NEMECP) Apply for CDC RFA TS14 1401 Funding Number: CDC RFA TS14 1401 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis TIPS) among Non urban Young Persons Who Inject Drugs Apply for RFA PS 14 004 Funding Number: RFA PS 14 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| National Diabetes Prevention Program Preventing Type 2 Diabetes Among People at High Risk Apply for CDC RFA DP12 121203CONT14 Funding Number: CDC RFA DP12 121203CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| High Impact Neuroscience Research Resource Grants (R24) Apply for RFA NS 14 006 Funding Number: RFA NS 14 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Studies of Mental Illness Not Involving Treatment Development, Efficacy, or Effectiveness Trials (Collaborative R01) Apply for PAR 14 165 Funding Number: PAR 14 165 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Warrenton, GA Apply for HRSA 14 136 Funding Number: HRSA 14 136 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,185,045 |
| Biology of Manual Therapies (R21) Apply for PA 14 167 Funding Number: PA 14 167 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Biology of Manual Therapies (R01) Apply for PA 14 168 Funding Number: PA 14 168 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Affordable Care Act and What it Means for People with Disabilities Apply for NCD0114 Funding Number: NCD0114 Agency: National Council on Disability Category: Health Funding Amount: $135,000 |
| Fetal Alcohol Spectrum Disorders Practice and Implementation Centers Apply for CDC RFA DD14 1402 Funding Number: CDC RFA DD14 1402 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
| Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through National Partnerships Apply for CDC RFA DD14 1403 Funding Number: CDC RFA DD14 1403 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| COMPREHENSIVE COMMUNITY HIV PREVENTION PROJECT FOR KEY AND VULNERABLE POPULATIONS (CP2) Apply for RFI CP2 TANZANIA Funding Number: RFI CP2 TANZANIA Agency: Agency for International Development Category: Health Funding Amount: $74,999,999 |
| Evaluation of Health Promotion and Prevention Programs for Blood Disorders Apply for CDC RFA DD14 1405 Funding Number: CDC RFA DD14 1405 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Maintenance and Enhancement of the Environmental Public Health Tracking Network Apply for CDC RFA EH14 1403 Funding Number: CDC RFA EH14 1403 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $900,000 |
| Innovative Programs to Enhance Research Training (IPERT) (R25) Apply for PAR 14 170 Funding Number: PAR 14 170 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Claude D. Pepper Older Americans Independence Centers (P30) Apply for RFA AG 15 003 Funding Number: RFA AG 15 003 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| HIV/AIDS Policy Initiative Building State, County and Local Public Health Infrastructure Apply for CDC RFA PS10 104505CONT14 Funding Number: CDC RFA PS10 104505CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Newborn Screening Data Repository and Technical Assistance Center Apply for HRSA 14 089 Funding Number: HRSA 14 089 Agency: Health Resources and Services Administration Category: Health Funding Amount: $850,000 |
| Behavioral Health Workforce Education and Training for Professionals Apply for HRSA 14 077 Funding Number: HRSA 14 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: $480,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 131502CONT14", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.